Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Propofol With Ketogenic Diet: Is That a Real Contraindication? A Cas…

Niraj Arora

Cognitive Disorders

ZINCARE

M. Mataa

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

Embracing Aging: Helping Our Loved Ones, Helping Ourselves

Pacific Neuroscience Institute

S. Kaiser, A. Effinger

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Reducing the Burden of Traumatic Brain Injuries by Improving Recovery

BRAIN PONDERINGS podcast with Mark Mattson

D. Menon, M. Mattson

Penetrating TBI Algorithms

UChicago Medicine

A. Valadka

Mild Traumatic Brain Injury

Providence Swedish

J. E. Benson

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Aducanumab: What Neurologists Should Know - Clinical Impact, Indicat…

Northwestern Medicine Neurology and Neurosurgery

I. Grant

Updates in Dementia

2023 Conference Coverage

P. Tipton

AAIC 2024 Insights: Effects of Gut Microbiota Dysbiosis on Cognitive…

AAIC 2024 Insights Hub

Y. (Laura) Zhang

Neuropsychological Assessment in Dementia Diagnosis

Northwestern Medicine Neurology and Neurosurgery

S. Weintraub

Preventing Cognitive Decline with Lithium

Psychiatry Redefined

J. Greenblatt

Alzheimer's: Clinical Pearls

Lawrence Robbins

Year in Review: Advancements in Biomarkers for Alzheimer's Disease a…

Neurology 2024 Year in Review

S. Schindler

An Update on Alzheimer's Disease: New Strategies Across the Disease …

Miller Medical Communications

P. Tariot

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay